Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer

NCT02672098 is registered in ClinicalTrials.gov with Loma Linda University as lead sponsor.

NCT NCT02672098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02672098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
Lead sponsor
Loma Linda University
Phase
Phase 1
Overall status
Completed
Start date
July 14, 2016
Completion date
April 19, 2023
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer